Novavax Booster Authorization

Commissioner Lambrew letterhead

To: Maine Immunization Program Providers

From: Maine Immunization Program

Subject: Novavax Booster Authorization 

Date: October 20, 2022

 

The CDC’s Advisory Committee on Immunization Practices’ (ACIP) has now authorized the Novavax monovalent COVID-19 boosters for to be administered to people ages 18 years and older targeting the original COVID-19 strain. This recommendation followed the FDA’s granting of emergency use authorization.

The Novavax monovalent COVID-19 boosters may be given to adults if they:

  • are 18 years or older,
  • have completed a primary series vaccination,
  • have not previously received a COVID-19 booster and,
  • cannot or will not receive an updated mRNA booster.

The Novavax COVID-19 vaccine booster is a 0.5 mL dose and may be administered at least 6 months after completion of primary vaccination with an authorized or approved COVID-19 vaccine.

Resources 

Below is a list of resources and upcoming informational activities related to the recommendations.

If you have any questions, please contact the Maine Immunization Program at (207) 287-3746 or email: ImmunizeME.DHHS@maine.gov.

Thank you for your continued efforts to ensure that all Mainers have access to COVID-19 vaccination.